lung disease

penguins jump water swim leap splash
Biotech

Insmed's shares double as lung disease med powers past phase 3

Insmed’s medicine didn’t just reduce exacerbations of a chronic lung disease in a phase 3 trial. It blew the primary endpoint out of the water.
Annalee Armstrong May 28, 2024 10:32am
Lung model

Vicore's IPF drug improves lung function in phase 2 win

May 20, 2024 2:00am
Lung Fibrosis

Surrozen's Wnt mimetic antibody works in mice with lung fibrosis

Apr 4, 2024 4:30am
pipeline pipes development workers

Brii punts HIV, depression, lung programs to potential partners

Mar 22, 2024 11:34am
Getty

Insilico 'pulls back the curtain' in paper on AI drug discovery

Mar 8, 2024 5:00am
failure crash no fail rocket cancelled end

AN2's stock craters as lead lung disease phase 3 trial paused

Feb 12, 2024 8:16am